IndiaTickerKwality Pharmaceuticals Ltd - 539997 - Disclosure Under Regulation 30 Of SEBI LODRBSE · exchange filing · pdf
Source filing Company dossier
Kwality Pharmaceuticals
NSE:KPL · ISIN INE552U01010
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Kwality Pharmaceuticals
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Kwality Pharmaceuticals Ltd - 539997 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Resignation of DirectorBSE · exchange filing · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · conference call · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · audio
Source filing Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE · conference call · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Audited Financial Results For The Quarter And Year Ended 31St March, 2026.BSE · financial results · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended 31St March, 2026BSE · financial results · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Board Meeting Intimation for Considering The Standalone & Consolidated Audited Financial Results For The Quarter And Year Ended March 31, 2026BSE · financial results · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Credit RatingBSE · credit rating · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ABSE · exchange filing · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotBSE · exchange filing · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportBSE · exchange filing · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Update On Bioequivalence (BE) Program - Successful Completion Of Phase 1 By Kwality Pharmaceuticals Ltd.BSE · exchange filing · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Shareholder Meeting / Postal Ballot-Notice of Postal BallotBSE · exchange filing · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · other
Source filing Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · exchange filing · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · other
Source filing Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · exchange filing · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Investor Presentation Of Financial Results For The Quarter And Nine Months Ended December 31, 2025BSE · investor presentation · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31-12-2025BSE · financial results · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Board Meeting Outcome for Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025BSE · financial results · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended On 31St December, 2025.BSE · financial results · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Kwality Pharmaceuticals Ltd - 539997 - Board Meeting Outcome for Appointment Of Mr. Bhavesh Mahajan (DIN: 09614108) As Additional Independent Director Of The CompanyBSE · exchange filing · pdf
Source filing